Global Ophthalmoplegia Market Size
Market Size in USD Mn
CAGR7.7%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 7.7% |
| Market Concentration | High |
| Major Players | Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Global Ophthalmoplegia Market Analysis
The ophthalmoplegia market is estimated to be valued at USD 549.3 Mn in 2025 and is expected to reach USD 923.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.
There is an increasing trend seen in the ophthalmoplegia market owing to rising cases of neurological disorders that often cause ophthalmoplegia. The growing geriatric population worldwide who are more prone to such neurological conditions is also contributing to the growth of this market. Moreover, development of advanced treatment options and improving healthcare infrastructure in developing nations have helped in greater diagnosis of ophthalmoplegia cases thereby spurring market revenues.